The role of Vif during HIV-1 infection: Interaction with novel host cellular factors

Journal of Clinical Virology

Volumn 26, Issue 2, 2003, Pages 143-152

  Lake, Julie Anne ^a   Carr, Jillian ^a   Feng, Feng ^a   Mundy, Linda ^a   Burrell, Christopher ^a,b   Li, Peng ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

HIV 1; HIV 1 replication; Host cellular factors; Virion infectivity factor

Indexed keywords

ADENOSINE TRIPHOSPHATE; COMPLEMENTARY DNA; INTERMEDIATE FILAMENT PROTEIN; VIF PROTEIN;

ARTICLE; CELL DIVISION; CONTROLLED STUDY; DNA LIBRARY; GENBANK; GENE IDENTIFICATION; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMEDIATE FILAMENT; LEUKOCYTE; MEDICAL RESEARCH; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; VIRUS REPLICATION; YEAST;

GENE PRODUCTS, VIF; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; RNA, VIRAL; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES; VIMENTIN; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0037319391     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00113-0     Document Type: Article

References (44)

1. Baraz L., Friedler A., Blumenzweig I., Nussinuv O., Chen N., Steinitz M., et al. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production. FEBS Lett. 441:1998;419-426.
2. Borman A.M., Quillent C., Charneau P., Dauguet C., Clavel F. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69:1995;2058-2067.
3. Bouyac M., Rey F., Nascimbeni M., Courcoul M., Sire J., Blanc D., et al. Phenotypically Vif-human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 71:1997;2473-2477.
4. Bukrinskaya A., Brichacek B., Mann A., Stevenson M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188:1998;2113-2125.
5. Camaur D., Trono D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:1996;6106-6111.
6. Colombatto S., De Agostini M., Corsi D., Sinicco A. Polyamines in lymphocytes from patients infected by human immunodeficiency virus. Biol. Chem. Hoppe-Seyler. 370:1989;745-748.
7. Cullen B.R. HIV-1 auxiliary proteins: making connections in a dying cell. Cell. 93:1998;685-692.
8. D'Aloja P., Olivetta E., Bona R., Nappi F., Pedacchia D., Pugliese K., et al. Gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (Hiv-1) variant: identification of novel Hiv-1-inhibiting viral protein mutants. J. Virol. 72:1998;4308-4319.
9. Dettenhofer M., Cen S., Carlson B.A., Kleiman L., Yu X.F. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol. 74:2000;8938-8945.
10. Dettenhofer M., Yu X.F. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1999;1460-1467.
11. Dornadula G., Yang S., Pomerantz R.J., Zhang H. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from non permissive cells by intravirion reverse transcription. J. Virol. 74:2000;2594-2602.
12. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 372:1994;359-362.
13. Harrington M., Carpenter C.C. Hit HIV-1 hard, but only when necessary. Lancet. 355:2000;2147-2152.
14. Hassaine G., Courcoul M., Bessou G., Barthalay Y., Picard C., Olive D., et al. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral Vif protein. J. Biol. Chem. 276:2001;16885-16893.
15. Henzler T., Harmache A., Herrmann H., Spring H., Suzan M., Audoly G., et al. Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure. J. Gen. Virol. 82:2001;561-573.
16. Howe A.Y., Jung J.U., Desrosiers R.C. Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J. Virol. 72:1998;9827-9834.
17. Igarashi K., Kashiwagi K. Polyamines: mysterious modulators of cellular functions. Biochem. Biophys. Res. Comm. 271:2000;559-564.
18. Inubushi R., Adachi A. Cell-dependent function of HIV-1 Vif for virus replication. Int J Mol Med 1999;3:473-6.
19. Karczewski M.K., Strebel K. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70:1996;494-507.
20. Khan M.A., Aberham C., Kao S., Akari H., Gorelick R., Bour S., et al. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol. 75:2001;7252-7265.
21. Luban J. Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell. 87:1996;1157-1159.
22. Madani N., Kabat D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72:1998;10251-10255.
23. Mahalingam S., Ayyavoo V., Patel M., Kieber-Emmons T., Kao G.D., Muschel R.J., et al. HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. USA. 95:1998;3419-3424.
24. Mouland A.J., Mercier J., Luo M., Bernier L., DesGroseillers L., Cohen E.A. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J. Virol. 74:2000;5441-5451.
25. Ohagen A., Gabuzda D. Role of Vif in stability of the human immunodeficiency virus type 1 core. J. Virol. 74:2000;11055-11066.
26. Sakai K., Horiuchi M., Iida S., Fukumori T., Akari H., Adachi A. Mutational analysis of human immunodeficiency virus type 1 Vif gene. Virus Genes. 18:1999;179-181.
27. Simm M., Shahabuddin M., Chao W., Allan J.S., Volsky D.J. Aberrant Gag protein composition of a human immunodeficiency virus type 1 Vif mutant produced in primary lymphocytes. J. Virol. 69:1995;4582-4586.
28. Simon J.H., Carpenter E.A., Fouchier R.A., Malim M.H. Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in co-localizing membrane-free cytoplasmic complexes. J. Virol. 73:1999;2667-2674.
29. Simon J.H., Gaddis N.C., Fouchier R.A., Malim M.H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4:1998;1397-1400.
30. Simon JH, Fouchier RA, Southerling TE, Guerra CB, Grant CK, and Malin MH. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalise in infected human T-cells. J Virol 1997;71(7):5259-67.
31. Simon J.H., Malim M.H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70:1996;5297-5305.
32. Simon J.H., Miller D.L., Fouchier R.A., Malim M.H. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function. Virology. 248:1998;182-187.
33. Simon J.H., Miller D.L., Fouchier R.A., Soares M.A., Peden K.W., Malim M.H. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17:1998;1259-1267.
34. Simon J.H., Sheehy A.M., Carpenter E.A., Fouchier R.A., Malim M.H. Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J. Virol. 73:1999;2675-2681.
35. Soll D.R. Researchers in cell motility and the cytoskeleton can play major roles in understanding AIDS. Cell Motil. Cytoskeleton. 37:1997;91-97.
36. Sova P., Volsky D.J. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with Vif-negative human immunodeficiency virus type 1. J. Virol. 67:1993;6322-6326.
37. Sova P., Volsky D.J., Wang L., Chao W. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed Gag. J. Virol. 75:2001;5504-5517.
38. van der Reijden B.A., Erpelinck-Verschueren C.A., Lowenberg B., Jansen J.H. TRIADs: a new class of proteins with a novel cysteine-rich signature. Protein Sci. 8:1999;1557-1561.
39. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
40. Yang S., Sun Y., Zhang H. The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J. Biol. Chem. 276:2001;4889-4893.
41. Yang X., Gabuzda D. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J. Virol. 73:1999;3460-3466.
42. Zhang H., Dornadula G., Pomerantz R.J. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments: an important stage for viral infection of nondividing cells. J. Virol. 70:1996;2809-2824.
43. Zhang H., Pomerantz R.J., Dornadula G., Sun Y. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J. Virol. 74:2000;8252-8261.
44. Zimmerman C., Klein K.C., Kiser P.K., Singh A.R., Firestein B.L., Riba S.C., et al. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature. 415:2002;88-92.